<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0031">
 <label>31</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hafner</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mills</surname>
    <given-names>CE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Subramanian</surname>
    <given-names>K</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Multiomics profiling establishes the polypharmacology of FDA-approved CDK4/6 inhibitors and the potential for differential clinical activity</article-title>. 
  <source>Cell Chem Biol</source>
  <year>2019</year>;
  <volume>26</volume>:
  <fpage>1067</fpage>–
  <lpage>80</lpage>.
  <pub-id pub-id-type="pmid">31178407</pub-id>
 </mixed-citation>
</ref>
